← Back to Analyst Consensus 
OBX Buy
Obsidian Therapeutics, Inc.
Current Price —
Implied Upside —
Analysts 9
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Sep 22, 2026 | Leerink Partners | initiate | — → Outperform | — | 51% |
| Sep 9, 2026 | William Blair | initiate | — → Outperform | — | 48% |
| Aug 18, 2026 | LifeSci Capital | initiate | — → Outperform | — | 57% |
| Aug 5, 2026 | Piper Sandler | initiate | — → Overweight | — | 54% |
Price Target Trend
Aug 6, 2026 Latest: $39 Oct 25, 2026
EPS Estimates
+1q $-0.51
Lo: $-0.61 Hi: $-0.41
3 analysts 0y $-1.82
Lo: $-2.62 Hi: $-1.00
3 analysts +1y $-2.79
Lo: $-3.85 Hi: $-2.13
4 analysts 0q $-0.42
Lo: $-0.47 Hi: $-0.38
3 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days